ALK-Scherax Arzneimittel

ALK-Abelló is a global pharmaceutical company specializing in allergy immunotherapy (AIT), aimed at treating the underlying cause of allergic diseases. The company offers a comprehensive portfolio of products, including sublingual immunotherapy (SLIT) tablets, subcutaneous immunotherapy (SCIT) injections, and sublingual drops. Its flagship tablet portfolio includes Acarizax, Grazax, and Itulazax, which target house dust mites, grass pollen, and tree pollen, respectively. Beyond immunotherapy, the company provides emergency treatments for severe allergic reactions, most notably the Jext adrenaline auto-injector. ALK-Abelló operates with a significant presence in Europe and North America, focusing on clinical evidence and patient-centric solutions to manage allergic rhinitis and asthma. The German subsidiary, formerly known as ALK-Scherax, represents a key component of its commercial operations in the world's largest AIT market.